Patents by Inventor Alexei Evlachev

Alexei Evlachev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF IMMUNE DEPRESSION
    Publication number: 20230256057
    Abstract: The present invention is in the field of immunotherapy. The invention provides non-propagative viral vectors comprising a nucleic acid molecule encoding at least a polypeptide having an IL-7 activity, wherein said non-propagative viral vector is for use in the treatment of immune depression induced by sepsis, burn, trauma, major surgery, senescence and/or coronavirus.
    Type: Application
    Filed: July 13, 2021
    Publication date: August 17, 2023
    Applicant: Transgene
    Inventors: Geneviève INCHAUSPE, Perrine MARTIN, Stéphane LEUNG-THEUNG-LONG, Karine LELU-SANTOLARIA, Alexei EVLACHEV, Charles Antoine COUPET, Aurélie RAY, Clarisse DUBOIS
  • Composition for treating HBV infection
    Patent number: 10857226
    Abstract: The present invention provides a composition comprising hepatitis B virus (HBV) component(s), and which may be either nucleic acid- or polypeptide-based as well as nucleic acid molecules and vectors encoding such HBV component(s). It also relates to infectious viral particles and host cells comprising such nucleic acid molecules or vectors. It also provides composition and kits of parts comprising such nucleic acid molecules, vectors, infectious viral particles or host cells and the therapeutic use thereof for preventing or treating HBV infections.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: December 8, 2020
    Assignee: Transgene S.A.
    Inventors: Perrine Martin, Geneviève Inchauspe, Nathalie Silvestre, Doris Schmitt, Alexei Evlachev
  • COMPOSITION FOR TREATING HBV INFECTION
    Publication number: 20190070285
    Abstract: The present invention provides a composition comprising hepatitis B virus (HBV) component(s), and which may be either nucleic acid- or polypeptide-based as well as nucleic acid molecules and vectors encoding such HBV component(s). It also relates to infectious viral particles and host cells comprising such nucleic acid molecules or vectors. It also provides composition and kits of parts comprising such nucleic acid molecules, vectors, infectious viral particles or host cells and the therapeutic use thereof for preventing or treating HBV infections.
    Type: Application
    Filed: September 17, 2018
    Publication date: March 7, 2019
    Applicant: Transgene S.A.
    Inventors: Perrine Martin, Geneviève Inchauspe, Nathalie Silvestre, Doris Schmitt, Alexei Evlachev
  • Composition for treating HBV infection
    Patent number: 10076570
    Abstract: The present invention provides a composition comprising hepatitis B virus (HBV) component(s), and which may be either nucleic acid- or polypeptide-based as well as nucleic acid molecules and vectors encoding such HBV component(s). It also relates to infectious viral particles and host cells comprising such nucleic acid molecules or vectors. It also provides composition and kits of parts comprising such nucleic acid molecules, vectors, infectious viral particles or host cells and the therapeutic use thereof for preventing or treating HBV infections.
    Type: Grant
    Filed: March 17, 2012
    Date of Patent: September 18, 2018
    Assignee: Transgene S.A.
    Inventors: Perrine Martin, Geneviève Inchauspe, Nathalie Silvestre, Doris Schmitt, Alexei Evlachev
  • COMPOSITION FOR TREATING HBV INFECTION
    Publication number: 20120251569
    Abstract: The present invention provides a composition comprising hepatitis B virus (HBV) component(s), and which may be either nucleic acid- or polypeptide-based as well as nucleic acid molecules and vectors encoding such HBV component(s). It also relates to infectious viral particles and host cells comprising such nucleic acid molecules or vectors. It also provides composition and kits of parts comprising such nucleic acid molecules, vectors, infectious viral particles or host cells and the therapeutic use thereof for preventing or treating HBV infections.
    Type: Application
    Filed: March 17, 2012
    Publication date: October 4, 2012
    Applicant: TRANSGENE SA
    Inventors: Perrine Martin, Geneviève Inchauspe, Nathalie Silvestre, Doris Schmitt, Alexei Evlachev